S&R advised Kotak, Goldman & Others on the IPO of Glenmark Life Sciences
S&R Associates represented Kotak Mahindra, BofA Securities, Goldman Sachs, DAM Capital, BOB Capital Markets and SBI Capital
story
S&R advised Kotak, Goldman & Others on the IPO of Glenmark Life Sciences S&R Associates represented Kotak Mahindra, BofA Securities, Goldman Sachs, DAM Capital, BOB Capital Markets and SBI Capital Markets, book running lead managers, in the INR 15.14 billion initial public offering by Glenmark Life Sciences Limited, a leading developer and manufacturer of select high...
S&R advised Kotak, Goldman & Others on the IPO of Glenmark Life Sciences
S&R Associates represented Kotak Mahindra, BofA Securities, Goldman Sachs, DAM Capital, BOB Capital Markets and SBI Capital Markets, book running lead managers, in the INR 15.14 billion initial public offering by Glenmark Life Sciences Limited, a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas.
The S&R team included partners Sandip Bhagat and Jabarati Chandra, and associates Pratichi Mishra, Dhanush Dinesh and Somya Pahi Jena.